How VR, nanotechnology, and 3D printing could improve the value of healthcare; 100 experimental therapies in late-stage clinical trials; Kite Pharma plans “controlled” launch of CAR-T therapy
Five things for pharma marketers to know: Wednesday, November 30, 2016
The drugmaker’s new EVP of worldwide commercial operations also talks about tackling medication access, product launches, and starting a commercial team from scratch.
Two new therapies made by Sanofi and Novo Nordisk to compete in crowded diabetes market